Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy
Orphanet J Rare Dis
.
2019 Apr 2;14(1):75.
doi: 10.1186/s13023-018-0975-3.
Authors
Erik Landfeldt
1
2
,
Hanns Lochmüller
3
4
5
,
Peter Lindgren
6
Affiliations
1
Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, SE-17177, Stockholm, Sweden. erik.landfeldt@ki.se.
2
ICON plc, Stockholm, Sweden. erik.landfeldt@ki.se.
3
Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, Medical Centre - University of Freiburg, Freiburg, Germany.
4
Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Canada.
5
Division of Neurology, Department of Medicine, The Ottawa Hospital, Ottawa, Canada.
6
Medical Management Centre, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
PMID:
30940156
PMCID:
PMC6446357
DOI:
10.1186/s13023-018-0975-3
No abstract available
Publication types
Letter
Review
MeSH terms
Cost of Illness
Humans
Muscular Dystrophy, Duchenne / economics*